5:46 PM
 | 
Feb 21, 2014
 |  BC Extra  |  Financial News

Progenics raises $35 million in follow-on

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) raised $35 million through the sale of 7.6 million shares at $4.60 in a follow-on underwritten by Jefferies; Needham; and Brean Capital. Progenics proposed the offering late...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >